Your session is about to expire
← Back to Search
Risk-Based Therapy for Liver Cancer
Study Summary
This trial looks at side effects and effectiveness of different treatments for newly diagnosed liver cancer in young patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My early-stage cancer tissue wasn't reviewed within 2 weeks after surgery.I have not had chemotherapy, other cancer drugs, or experimental treatments recently.I have not had an organ transplant, am not pregnant or breastfeeding, and do not have an uncontrolled infection.I am not taking steroids, seizure medications, blood thinners, or ACE inhibitors.I have not had major surgery in the last 6 weeks.I have been recently diagnosed with hepatoblastoma.My condition requires urgent treatment due to a tumor affecting vital organ function or blood clotting issues.I was diagnosed with hepatoblastoma, met all criteria before emergency treatment, and had a confirmed diagnosis.My cancer's stage and treatment plan follows COG guidelines.I can take care of myself and perform daily activities.I am stage I and won't need chemotherapy, so my organ function isn't a concern.I am not taking strong medications that affect liver enzymes.I am using effective birth control.I have not received chemotherapy or specific treatments for hepatoblastoma before.
- Group 1: Very low-risk group
- Group 2: Low-risk group (regimen T)
- Group 3: High-risk group (regimen H)
- Group 4: Intermediate-risk group (regimen F)
- Group 5: High-risk group (regimen W)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are currently being treated with this medication?
"28 other clinical trials for hepatoblastoma and 1706 liver transplant studies are actively recruiting patients. The mentioned trial, however, is not presently admitting new participants."
Why is Liver Transplantation a common treatment?
"neoplasm metastasis, stiff shoulder, and advanced testicular cancer can all be remedied through Liver Transplantation."
What is the most recent FDA decision on liver transplants?
"Liver Transplantation received a score of 3 because there is prior clinical data supporting its safety, meaning that it's efficacious and has undergone multiple rounds of testing."
Could you please tell me how many research sites are presently conducting this trial?
"There are 100 sites currently running this trial. If you enroll, it would be advantageous to choose a location near you to limit travel. The locations of the clinics are in Dallas, Jackson, Detroit and other cities."
Are investigators still looking for more people to enroll in this research project?
"This study is no longer recruiting patients. The trial was first posted on September 14th, 2009 and was last edited on September 16th, 2022. However, there are 28 trials currently enrolling patients with hepatoblastoma and 1706 studies for Liver Transplantation that are actively recruiting participants."
Has a study like this been done before?
"Liver Transplantation has been an active area of research since 1997. After the first Phase 3 clinical trial in 1997, which was sponsored by Alfacell and involved 300 patients, Liver Transplantation received drug approval. Currently, there are 1706 active trials for this procedure being conducted across 3952 cities and 81 countries."
Are there other examples of research involving Liver Transplantation?
"The very first study on liver transplantation was completed in 1997 at Spectrum Health Hospital - Butterworth Campus. As of now, a total of 3366 studies have been conducted. There are 1706 active trials underway as we speak, with many of these taking place in Dallas, Texas."
Share this study with friends
Copy Link
Messenger